Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)
Dominic Millenaar, Helmut Schumacher, Martina Brueckmann, John W. Eikelboom, Michael D. Ezekowitz, Jonathan Slawik, Sebastian Ewen, Christian Ukena, Lars Wallentin, Stuart J. Connolly, Salim Yusuf, Michael Böhm
Topics & Concepts
MedicinePolypharmacyAtrial fibrillationInternal medicineStroke (engine)Hazard ratioHeart failureDiabetes mellitusCardiologyBody mass indexWarfarinProportional hazards modelCoronary artery diseaseConfidence intervalMechanical engineeringEndocrinologyEngineeringAtrial Fibrillation Management and OutcomesMedication Adherence and ComplianceCardiac Arrhythmias and Treatments